NASDAQ
Aridis Pharmaceuticals, Inc. (ARDS) has a interest coverage ratio of -79.35x as of Friday, May 29, 2026. This represents a 362.32% decrease compared to its 12-month average of 30.25x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.